Showing results (501-510 of 1,134) with videos related to
Sort By:
Pageof 114
Antimicrobial Agents and Chemotherapy|July 1, 1993
Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolatesC A Boucher, R van Leeuwen, P Kellam, et al.Virology Journal|May 18, 2022
Non-linear transformation of enzyme-linked immunosorbent assay (ELISA) measurements allows usage of linear models for data analysisThomas M Lange, Maria Rotärmel, Dominik Müller, et al.AIDS (London, England)|November 1, 1989
Disseminated cat-scratch disease in a patient with AIDSP A van der Wouw, R J Hadderingh, P Reiss, et al.AJNR. American Journal of Neuroradiology|November 13, 2020
National Trends in Lumbar Puncture from 2010 to 2018: A Shift Reversal from the Emergency Department to the Hospital Setting for Radiologists and Advanced Practice ProvidersL M Trunz, A V Gandhi, A D Karambelkar, et al.Cancer Medicine|February 24, 2021
Prostate-specific antigen testing among young men: an opportunity to improve valueSuzanne M Lange, Jacob P Ambrose, Michael C Flynn, et al.Mayo Clinic Proceedings|May 13, 1999
Probable alcohol abuse or dependence: a risk factor for intensive-care readmission in patients undergoing elective vascular and thoracic surgical procedures. Mayo Perioperative Outcomes GroupP M Maxson, K L Schultz, K H Berge, et al.International Journal of Oncology|May 12, 2011
Analysis of breast-tissue cathepsin-d isoforms from patients with breast-cancer, benign breast disease and from normal controlsS Bazel, K Ferry, F Shoarinejad, et al.Journal of the American Academy of Dermatology|September 1, 1990
Human immunodeficiency virus exanthemH J Hulsebosch, F A Claessen, C J van Ginkel, et al.The Journal of Infectious Diseases|October 20, 2005
Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapyMiriam Casula, Gerrit Jan Weverling, Ferdinand W Wit, et al.Journal of Medical Economics|May 20, 2009
Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed populationQuan V Doan, Stephen M Lange, Adam Elfant, et al.Pageof 114